Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
NCT: NCT06105892 · RECRUITING
Brief Summary
This study will test a portable virtual reality (VR) system with integrated eye tracking called Virtual Eye Rotation Vision Exercises (VERVE). The proposed VERVE platform will deliver vergence therapy in an automated manner. This research will involve 30 non-traumatic brain injury (TBI) binocularly normal (BNC) Veterans and 50 post-traumatic convergence insufficiency (PTCI) Veterans who will undergo Active and Sham therapy (equally divided groups) to determine the effectiveness of VERVE vergence therapy.
Frequently Asked Questions
What is Eye Recovery Automation for Post Injury Dysfunction (iRAPID)?
Eye Recovery Automation for Post Injury Dysfunction (iRAPID) is a clinical trial registered under NCT06105892. Current status: RECRUITING.
What is the status of NCT06105892?
The current status of NCT06105892 (Eye Recovery Automation for Post Injury Dysfunction (iRAPID)) is: RECRUITING.
When did Eye Recovery Automation for Post Injury Dysfunction (iRAPID) start?
Eye Recovery Automation for Post Injury Dysfunction (iRAPID) started on 2023-10-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.